What question did this study set out to answer?

The value of hysterectomy in the management of gestational trophoblastic neoplasia: a retrospective analysis

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis reveals first-line hysterectomy reduces chemotherapy needs in low-risk gestational trophoblastic neoplasia.

This analysis aims to evaluate the outcomes of hysterectomy in the management of gestational trophoblastic neoplasia (GTD), focusing on treatment intensity and survival.
Conducted a retrospective analysis from 2014 to 2023 on patients undergoing hysterectomy for GTD.
Collected data on demographics, surgery indications, chemotherapy use, and outcomes.
Examined the impact of timing of surgery on chemotherapy cycles needed for remission.
First-line hysterectomy patients required fewer chemotherapy cycles (median 2) than non-first-line patients (median 7).
Low-risk patients achieved cure with primary surgery alone, reducing chemotherapy exposure.
Overall survival rate for the cohort was 95%.

Niu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark